ID
45292
Description
Principal Investigator: Vamsi Mootha, MD, Department of Systems Biology, Harvard Medical School; Department of Medicine, Massachusetts General Hospital; Broad Institute of MIT and Havard, Boston, MA, USA MeSH: Mitochondrial Diseases,Mitochondrial Disorders,Mitochondrial Disorder,Oxidative Phosphorylation Deficiencies,Oxidative Phosphorylation Deficiency,Respiratory Chain Deficiencies, Mitochondrial,Respiratory Chain Deficiency,Mitochondrial Respiratory Chain Deficiencies,Electron Transport Chain Deficiencies, Mitochondrial,Mitochondrial Electron Transport Chain Deficiencies https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000339 Human disorders of mitochondrial oxidative phosphorylation (OXPHOS) represent a devastating collection of inherited diseases. These disorders impact at least 1:5000 live births, and are characterized by multi-organ system involvement. They are characterized by remarkable locus heterogeneity, with mutations in the mtDNA as well as in over 77 nuclear genes identified to date. It is estimated that additional genes may be mutated in these disorders. To discover the genetic causes of mitochondrial OXPHOS diseases, we performed targeted, deep sequencing of the entire mitochondrial genome (mtDNA) and the coding exons of over 1000 nuclear genes encoding the mitochondrial proteome. We applied this 'MitoExome' sequencing to 124 unrelated patients with a wide range of OXPHOS disease presentations from the Massachusetts General Hospital Mitochondrial Disorders Clinic. The 2.3Mb targeted region was captured by hybrid selection and Illumina sequenced with paired 76bp reads. The total set of 1605 targeted nuclear genes included 1013 genes with strong evidence of mitochondrial localization from the MitoCarta database, 377 genes with weaker evidence of mitochondrial localization from the MitoP2 database and other sources, and 215 genes known to cause other inborn errors of metabolism. Approximately 88% of targeted bases were well-covered (20X), with mean 200X coverage per targeted base.
Lien
Mots-clés
Versions (1)
- 15/10/2022 15/10/2022 - Adrian Schulz
Détendeur de droits
Vamsi Mootha, MD, Department of Systems Biology, Harvard Medical School; Department of Medicine, Massachusetts General Hospital; Broad Institute of MIT and Havard, Boston, MA, USA
Téléchargé le
15 octobre 2022
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
dbGaP phs000339 MitoExome Sequencing of Mitochondrial OXPHOS Diseases (MGH)
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Pedigree Information
- Subject - Sample - Mapping
- The dataset provides diagnostic (Bernier and Morava criteria) and sociodemographic, including age of onset, information. For the current version (.v2) data of several phenotype variables have been added, including information about clinical phenotypes observed among study participants.
- Sample Attribute Information
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject - Consent Information
- Pedigree Information
- Subject - Sample - Mapping
- The dataset provides diagnostic (Bernier and Morava criteria) and sociodemographic, including age of onset, information. For the current version (.v2) data of several phenotype variables have been added, including information about clinical phenotypes observed among study participants.
- Sample Attribute Information
C0680251 (UMLS CUI [1,2])
C0751651 (UMLS CUI [1,2])
C0679228 (UMLS CUI [1,3])
C0549184 (UMLS CUI [1,2])